Gate2Brain logo

Gate2Brain

Develops a brain tumour therapeutic candidate, with recent funding to support advancement of the program from its Barcelona base.

Deep Tech
Brain therapeutics
Total Raised
$7M
Last Valuation
$47M
Headquarters
Barcelona, Spain

Overview

Gate2Brain is a Barcelona-based company focused on advancing a brain tumour candidate. The available funding disclosure positions the business in therapeutic development rather than AI software, with its target market centered on oncology and brain tumour treatment. The company secured €7 million in an undisclosed round announced in June 2026. The financing is intended to advance its brain tumour candidate, giving Gate2Brain fresh capital to support development of its disclosed program.

Funding History

1 round · Jun 2026
$7M
Total Raised
1
Valuation: $47M
Cumulative: $7M

Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate

Investors not disclosed
Source

Frequently Asked Questions

How much has Gate2Brain raised in total?
Gate2Brain has raised a total of $7M across 1 funding round.
Who are Gate2Brain's investors?
Gate2Brain's investors include Undisclosed.
What does Gate2Brain do?
Gate2Brain is a Barcelona-based company focused on advancing a brain tumour candidate. The available funding disclosure positions the business in therapeutic development rather than AI software, with its target market centered on oncology and brain tumour treatment. The company secured €7 million in an undisclosed round announced in June 2026. The financing is intended to advance its brain tumour candidate, giving Gate2Brain fresh capital to support development of its disclosed program.
Where is Gate2Brain headquartered?
Gate2Brain is headquartered in Barcelona, Spain.